#United States #New York #Rosen Law Firm #Securities Class Action #Immutep Ltd

Rosen Law Firm Investigates Immutep Ltd.

Introduction

The Rosen Law Firm, a prominent global law firm specializing in investor rights, has announced its ongoing investigation into Immutep Ltd. (NASDAQ: IMMP) amid concerns regarding potentially misleading information disclosed to investors. This scrutiny arises following Immutep's press release that significantly impacted its stock market performance.

Recent Developments

On March 13, 2026, Immutep issued a press statement announcing the independent Data Monitoring Committee's (IDMC) decision to discontinue their TACTI-004 Phase III study, which involved the drug eftilagimod alfa, aimed at treating non-small cell lung cancer. This announcement came after a planned interim futility analysis, leading the committee to conclude that the trial should be halted due to insufficient efficacy.

This news sent shockwaves through the market, resulting in a staggering 82.6% decline in Immutep's American Depositary Receipt (ADR) price, which plummeted by $2.28 to close at $0.48. The drastic drop reflects the vulnerability of investors to misinformation and raises questions about the overall transparency in the company’s communications with its stakeholders.

Opportunities for Investors

Despite these concerns, Rosen Law Firm advises Immutep investors who purchased shares to consider seeking potential compensation through a class action lawsuit. The firm offers a contingency fee arrangement, meaning investors may not have to pay legal fees out of pocket. This arrangement allows those affected to recover losses incurred from their investments in Immutep.

Interested parties are encouraged to join the class action by visiting the Rosen Law Firm's website or contacting Phillip Kim, Esq. directly for additional information regarding participation.

Why Choose Rosen Law Firm?

Rosen Law Firm is recognized for its successful track record in handling securities class actions. In 2017, the firm was ranked number one in securities class action settlements by ISS Securities Class Action Services. With a commitment to achieving justice for investors, it has recovered substantial sums, with over $438 million secured in 2019 alone.

The firm stresses the importance of selecting experienced legal counsel. Many competing firms may lack the necessary resources or track record to effectively litigate such complex cases. By opting for Rosen Law Firm, investors are choosing seasoned attorneys who have demonstrated success in securing favorable outcomes for their clients.

Conclusion

The recent events surrounding Immutep Ltd. highlight the critical nature of transparency in corporate communications and the potential ramifications of alleged misinformation on investor confidence. As the Rosen Law Firm continues its investigation, it stands ready to assist shareholders seeking justice and recourse through collective legal action. Investors and affected parties should remain vigilant and informed about their rights during these challenging times.

For those interested in following updates or learning more about their options, Rosen Law Firm can be found on major social media platforms, including LinkedIn and Twitter. They are dedicated to keeping investors informed about developments relevant to their claims and the broader investment landscape.